| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Altimmune, Inc. | Director | Stock Options (option to buy) | 48,800 | 25 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ALT | Altimmune, Inc. | 25 Sep 2025 | 1 | $0 | 4 | Director | 29 Sep 2025, 16:13 |
| ALT | Altimmune, Inc. | 26 Sep 2024 | 1 | $0 | 4 | Director | 30 Sep 2024, 18:35 |
| ALT | Altimmune, Inc. | 28 Sep 2023 | 1 | $0 | 4 | Director | 29 Sep 2023, 18:01 |
| ALT | Altimmune, Inc. | 29 Sep 2022 | 1 | $0 | 4 | Director | 30 Sep 2022, 21:20 |
| ALT | Altimmune, Inc. | 23 Sep 2021 | 1 | $0 | 4 | Director | 24 Sep 2021, 20:46 |